LOS ANGELES (Reuters) The U.S Centers for Medicare and Medicaid Services (CMS) said on Wednesday it is reviewing its coverage of anemia drugs used to treat patients with kidney disease.The drugs, Epogen and Aranesp made by Amgen Inc and Procit made by Johnson & Johnson, have come under increased scrutiny after data from trials showed they could raise the risk of heart problems.The move was expe